An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a robust market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source.
Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.
Service Reaction and Content Removal
According to TikTok, the service has taken down violative content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at residence.
Within minutes of joining one group, a vendor posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Costs
Within these communities, posts show black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has already seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially significant medical dangers”.
